Ellevest Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $616K | Sell |
8,816
-708
| -7% | -$49.5K | 0.1% | 155 |
|
2025
Q1 | $700K | Sell |
9,524
-6,569
| -41% | -$483K | 0.05% | 147 |
|
2024
Q4 | $1.05M | Sell |
16,093
-5,080
| -24% | -$333K | 0.06% | 99 |
|
2024
Q3 | $1.65M | Sell |
21,173
-873
| -4% | -$68K | 0.09% | 67 |
|
2024
Q2 | $1.72M | Buy |
22,046
+4,344
| +25% | +$339K | 0.1% | 58 |
|
2024
Q1 | $1.2M | Buy |
17,702
+1,842
| +12% | +$125K | 0.07% | 80 |
|
2023
Q4 | $1.07M | Sell |
15,860
-529
| -3% | -$35.6K | 0.07% | 78 |
|
2023
Q3 | $1.11M | Buy |
16,389
+1,351
| +9% | +$91.5K | 0.09% | 62 |
|
2023
Q2 | $1.08M | Buy |
15,038
+286
| +2% | +$20.5K | 0.08% | 64 |
|
2023
Q1 | $1.02M | Buy |
14,752
+400
| +3% | +$27.8K | 0.08% | 63 |
|
2022
Q4 | $973K | Buy |
14,352
+2,231
| +18% | +$151K | 0.08% | 58 |
|
2022
Q3 | $665K | Sell |
12,121
-3,170
| -21% | -$174K | 0.06% | 72 |
|
2022
Q2 | $1.01M | Buy |
15,291
+1,230
| +9% | +$81.2K | 0.09% | 49 |
|
2022
Q1 | $933K | Buy |
14,061
+3,615
| +35% | +$240K | 0.08% | 59 |
|
2021
Q4 | $608K | Sell |
10,446
-775
| -7% | -$45.1K | 0.05% | 80 |
|
2021
Q3 | $674K | Buy |
11,221
+2,400
| +27% | +$144K | 0.07% | 73 |
|
2021
Q2 | $528K | Buy |
8,821
+2,280
| +35% | +$136K | 0.05% | 84 |
|
2021
Q1 | $325K | Buy |
6,541
+1,062
| +19% | +$52.8K | 0.04% | 117 |
|
2020
Q4 | $274K | Buy |
5,479
+1,116
| +26% | +$55.8K | 0.04% | 117 |
|
2020
Q3 | $239K | Buy |
4,363
+861
| +25% | +$47.2K | 0.04% | 114 |
|
2020
Q2 | $185K | Buy |
3,502
+1,324
| +61% | +$69.9K | 0.04% | 122 |
|
2020
Q1 | $97K | Buy |
2,178
+1,064
| +96% | +$47.4K | 0.03% | 143 |
|
2019
Q4 | $56K | Buy |
1,114
+865
| +347% | +$43.5K | 0.02% | 162 |
|
2019
Q3 | $11K | Buy |
249
+13
| +6% | +$574 | ﹤0.01% | 220 |
|
2019
Q2 | $10K | Buy |
+236
| New | +$10K | ﹤0.01% | 250 |
|